Have a personal or library account? Click to login
Concordance Between ER, PR, HER2 neu Receptors Before and After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Cover

Concordance Between ER, PR, HER2 neu Receptors Before and After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

Forum of Clinical Oncology
Volume 12 (2021): Issue 1 (May 2021)
By: Heba F. Taha,  Ola M. Elfarargy,  Reham A. Salem,  Doaa Mandour,  Amira A. Salem and  Mohamed Riad  
Open Access
|May 2021

Metrics

DOI: https://doi.org/10.2478/fco-2019-0021 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Journal RSS Feed
Language: English
Page range: 3 - 11
Submitted on: Jun 14, 2019
Accepted on: Dec 11, 2019
Published on: May 2, 2021
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Breast cancer,
neoadjuvant chemotherapy,
concordance between ER,
PR,
HER2 neu,
prognosis
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology

© 2021 Heba F. Taha, Ola M. Elfarargy, Reham A. Salem, Doaa Mandour, Amira A. Salem, Mohamed Riad, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 12 (2021): Issue 1 (May 2021)Next article